BRIEF-Novartis says 5-year data reinforce cosentyx leadership in spondyloarthritis

1 Min Read

Oct 16 (Reuters) - Novartis AG:

* NOVARTIS 5-YEAR DATA IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS REINFORCES COSENTYX® LEADERSHIP IN SPONDYLOARTHRITIS Source text for Eikon: Further company coverage: (Reporting By Zurich newsroom)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below